Change Lifestyle Before Giving Children Weight-Loss Medication, WHO Says
WHO’s first childhood obesity guidelines rule out weight-loss drugs under 10 and put lifestyle care before medicine for teens. What families should know.
Stay informed with the latest updates and insights on pharmaceuticals at Med Pharma News. Explore breaking news, industry trends, research advancements, and regulatory developments shaping the pharmaceutical landscape.
WHO’s first childhood obesity guidelines rule out weight-loss drugs under 10 and put lifestyle care before medicine for teens. What families should know.
AnnJi moves AJ201 (rosolutamide) into the pivotal Phase 3 ROMA-KD trial for spinal and bulbar muscular atrophy, also called Kennedy disease.
AAVantgarde reports early AAVB-081 results in Usher 1B (7 of 12 gained a line of vision) and preclinical AAVB-039 data for Stargardt disease.
Genmab reports a 45.9% response rate and 12.1-month response duration for Rina-S in platinum-resistant ovarian cancer. Data, safety and what is next.
London-based Samfara has made its first investment, backing a Danish maker of controlled-substance APIs. How the buyout works and what to watch.
Three companies, three assets, shared costs: how the AstraZeneca, Daiichi Sankyo and Summit trial pact works and what it signals for oncology deals.
A boiler explosion at the TIL Healthcare plant in Sri City, Andhra Pradesh killed five workers and injured over 10 on 3 October; cause is under probe.
Rakovina Celvion partnership uses the EMphora AI platform and real-world clinical data to guide ATR inhibitor development; no financial terms disclosed.
Ensera alliance network links SHL Medical, Stevanato, Ypsomed, Argonaut and American Injectables to speed drug-device combination product supply.